Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

New market launch for Azopt

June 30, 2000

Dura to launch second Allergan product

June 20, 2000

Alcon discovers utility of glutamate antagonists for retinal disorders

June 9, 2000

Allergan and Xoma expand rBPI ophthalmic program

June 6, 2000

Visudyne therapy receives Canadian approval for treatment of wet AMD

June 2, 2000

Angiotech signs license agreement with Alcon for delivery of paclitaxel

May 30, 2000

Early use of PDT with verteporfin in age-related macular degeneration

May 24, 2000

New agents for cataracts designed by Sankyo

May 22, 2000

Squalamine demonstrates preclinical activity in retinopathy

May 19, 2000

Ciba Vision and QLT expand strategic alliance for developing new treatments for eye diseases

May 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...